RHYTHM PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-33.7M | $-25.9M | $-11.1M |
| Depreciation & Amortization | $223.0K | $144.0K | — |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $2.3M | $1.2M | $298.0K |
| Net Cash from Operating Activities | $-29.5M | $-23.2M | $-7.0M |
| Investing Activities | |||
| Capital Expenditures | $133.0K | $1.1M | $17.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-110.0M | $-5.1M | $-17.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $167.2M | — | $41.7M |
| Net Change in Cash | $27.7M | $-28.3M | $34.7M |
| Free Cash Flow | $-29.6M | $-24.3M | $-7.0M |